Medicaid Formulary Changes, effective 4/01/2025
Date: 02/28/25
Medicaid Formulary Updates
Effective April 1, 2025
Effective April 1, 2025, Arizona Complete Health-Complete Care Plan (AzCH-CCP) will implement AHCCCS formulary changes based on the recommendations from the January 15, 2025, AHCCCS Pharmacy & Therapeutics (P & T) Committee meeting.
To review the AzCH-CCP Preferred Drug Lists (PDLs) including the recent updates, visit our website at: www.azcompletehealth.com > For Providers > Pharmacy > Preferred Drug Lists.
We encourage prescribing clinicians to review our PDLs for preferred formulary alternatives prior to prescribing. The table below highlights some of the upcoming formulary changes.
| Drug Class | Preferred | Non-Preferred | *Continuation of Non-Formulary Medication Permitted (Y/N) | Additional Requirements/Notes |
| Androgenic Agents | Testosterone Gel Packet (AG) (Vogelxo) (Transdermal) | No | ||
Enzyme Replacement Products, Gaucher Disease | Cerdelga (Oral) Cerezyme 400U (IV) Vpriv | Yes | ||
| Hypoglycemics, SGLT2s | Invokamet Invokana | No | ||
| Pulmonary Arterial Hypertension (PAH) Agents | Tracleer Suspension (Oral) | Bosentan Tablet (oral) Epoprostenol sodium (IV) Flolan (IV) Remodulin (Inj) Sildenafil (IV) Treprostinil (inj) Uptravi (IV) Veletri (IV) Winrevair Kit (SC) | Yes | PAH Injectable/IV products are available via the prior authorization process. |
*AHCCCS P&T determines whether to permit continued use of a non-formulary medication. If it is not permitted, members must switch to the preferred formulary alternative, and a new prescription may be required. (See AHCCCS Policy 310-V)
**Prior Authorization (PA), Step Therapy (STEP), Quantity Limit (QL), Age Restriction (AGE), Authorized Generic (AG)
If you have questions, please contact the AzCH-CCP Pharmacy Team at (888) 788-4408 (Options 3, 7).
Thank you!